Identification of a novel mutation in the PNLIP gene in two brothers with congenital pancreatic lipase deficiency

  1. Avraham Zeharia**,§§§
  1. *Raphael Recanati Genetics Institute, Schneider Children's Medical Center of Israel, Rabin Medical Center, Petah Tikva, Israel
  2. Felsenstein Medical Research Center, Schneider Children's Medical Center of Israel, Rabin Medical Center, Petah Tikva, Israel
  3. §Beilinson Campus, and Pediatric Genetics, Schneider Children's Medical Center of Israel, Rabin Medical Center, Petah Tikva, Israel
  4. **Day Hospitalization Unit, Schneider Children's Medical Center of Israel, Rabin Medical Center, Petah Tikva, Israel
  5. ††Molecular Medicine Laboratory, Rambam Medical Center, Haifa, Israel
  6. §§Laboratory of Clinical Biochemistry, Rambam Medical Center, Haifa, Israel
  7. ***Hematology Laboratory, Rambam Medical Center, Haifa, Israel
  8. †††The Lorry I. Lokey Interdisciplinary Center for Life Sciences and Engineering, Technion - Israel Institute of Technology, Haifa, Israel
  9. §§§Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
  10. ****Genetics and Genomic Medicine Laboratory, DNATraits, GenebyGene, Houston, TX

    Abstract

    Congenital pancreatic lipase (PNLIP) deficiency is a rare monoenzymatic form of exocrine pancreatic failure characterized by decreased absorption of dietary fat and greasy voluminous stools, but apparent normal development and an overall good state of health. While considered to be an autosomal recessive state affecting a few dozens of individuals world-wide and involving the PNLIP gene, no causative mutations for this phenotype were so far reported. Here, we report the identification of the homozygote missense mutation, Thr221Met [c.662C>T], in two brothers from a consanguineous family of Arab ancestry. The observed genotypes among the family members were concordant with an autosomal recessive mode of inheritance but moreover a clear segregation between the genotype state and the serum PNLIP activity was evident. Based on biophysical computational tools, we suggest the mutation disrupts the protein's stability and impairs its normal function. Although the role of PNLIP is well established, our observations provide genetic evidence that PNLIP mutations are causative for this phenotype.

    Footnotes

    • 1 To whom correspondence should be addressed. e-mail: d_behar{at}rambam.health.gov.il

    • Abbreviations:
      CLPS
      colipase
      PNLIP
      pancreatic lipase
      PT
      prothrombin time
      PTT
      partial thromboplastin time

    • This work was partially supported by the Humanitarian Genetic Counseling Fund, Rambam Medical Center.

    • Received March 26, 2013.
    • Revision received November 2, 2013.

    Author's Choice—Final version full access.

    Creative Commons Attribution Unported License applies to Author Choice Articles

    | Table of Contents epub_col2_image ePub download
    AUTHOR'S CHOICE

    This Article

    1. The Journal of Lipid Research, 55, 307-312.
    1. Free via Open Access: OA
    2. Free via Creative Commons: CC-BY license
    3. All Versions of this Article:
      1. jlr.P041103v1
      2. 55/2/307 most recent

    Article Usage Stats